How to write a prescription for Lantus (insulin glargine) 15 units subcutaneously every night at bedtime for a 1-month supply?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Write a Prescription for Lantus 15 Units at Bedtime for 1 Month

Write the prescription as: Lantus (insulin glargine) 100 units/mL, 15 units subcutaneously once daily at bedtime, dispense one 10 mL vial (or two 3 mL pens), with appropriate refills for ongoing therapy. 1

Prescription Components

Drug Name and Concentration

  • Specify "Lantus (insulin glargine) 100 units/mL" to ensure the correct formulation is dispensed 1
  • Always verify insulin labels before administration, as this is critical for patient safety 1

Dosing Instructions

  • Write "15 units subcutaneously once daily at bedtime" 1
  • The FDA label specifies that Lantus should be administered at the same time every day, though it can be given at any time of day 1
  • Bedtime dosing is a common and appropriate timing for basal insulin 1

Route and Site of Administration

  • Specify subcutaneous administration into the abdominal area, thigh, or deltoid 1
  • Include instruction to rotate injection sites within the same region to reduce risk of lipodystrophy and localized cutaneous amyloidosis 1

Quantity to Dispense

For a 1-month supply at 15 units daily:

  • Total units needed = 15 units/day × 30 days = 450 units
  • Dispense one 10 mL vial (contains 1000 units, sufficient for >2 months) 1
  • Alternative: Dispense two 3 mL SoloStar pens (each contains 300 units = 600 units total, sufficient for 40 days) 1

Additional Prescription Elements

  • Include appropriate refills (typically 11 refills for chronic therapy)
  • Add "Do not dilute or mix with any other insulin or solution" 1
  • Note that needles/syringes must never be shared between patients 1

Critical Safety Considerations

Monitoring Requirements

  • Instruct patient to increase frequency of blood glucose monitoring during initial therapy 1
  • Dosage adjustments should only be made under medical supervision with appropriate glucose monitoring 1

Important Warnings

  • Lantus is contraindicated during episodes of hypoglycemia 1
  • Do not administer intravenously or via an insulin pump 1
  • The solution should be clear and colorless with no visible particles before use 1

Common Pitfalls to Avoid

  • Never prescribe without specifying the concentration (100 units/mL) to avoid confusion with Toujeo (300 units/mL) 1
  • Do not write "qhs" alone - specify "once daily at bedtime" for clarity 1
  • Ensure adequate supply - prescribing exactly 450 units would leave no margin for error; a full vial or pen package is more practical 1
  • For patients with visual impairment using SoloStar pens, note that the pen dials in 1-unit increments and caution is needed 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.